CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
CENTENE CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$68.63−0.53 (-0.77%)
Close on Oct 19, 2026
- Market cap
- $34.15B
- P/E (TTM)
- –
- Dividend yield
- –
CENTENE CORP revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | $5.00B | $5.03B | $5.13B | $5.12B | $5.03B | $5.01B | $4.92B | $5.18B | $5.39B | $5.73B | $6.13B | $6.99B | 2.5% | -0.6% |
| Medicaid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Medicare | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Commercial | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium and service revenues | $178.66B | $176.75B | $174.58B | $166.15B | $158.15B | $151.66B | $145.51B | $144.55B | $142.62B | $141.48B | $140.10B | $138.31B | 88.0% | +13.0% |
| Premium | $175.57B | $173.73B | $171.56B | $163.10B | $155.09B | $148.49B | $142.30B | $141.02B | $138.77B | $137.34B | $135.64B | $133.29B | 86.5% | +13.2% |
| Service | $3.08B | $3.02B | $3.03B | $3.05B | $3.07B | $3.17B | $3.20B | $3.53B | $3.85B | $4.14B | $4.46B | $5.02B | 1.5% | +0.6% |
By region
From the segment and revenue-disaggregation notes of Centene's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.